We used a modified lamellar body phospholipid (LB-PL) assay to evaluate the effect of sample processing and to evaluate the clinical efficacy of LB-PL determinations. Withinrun and between-run CVs for the modified LB-PL assay respectively ranged from 2.9 to 6.7% and from 3.4 to 14.3%. Freezing and storage at -20 #{176}C did not affect results for LB-PL (n = 12). Statistically significant amounts of lamellar bodies were lost on centrifugation, ranging from 20% at 150 x g to 54% at 1000 x g for 5 mm. The LB-PL content, lecithin/sphingomyelin ratio, and phosphatidylglycerol content of 194 samples of amniotic fluid obtained within three days of delivery were compared for the assessment of fetal pulmonary maturity. Twenty-three neonates developed respiratory problems at or shortly after birth. With uncontaminated samples (n = 160), the LB-PL assay exhibited better speci- 
Assay sensitivities did not differ significantly. Differences among assay predictive values were not significant. here.
Materials and Methods

Materials
We used an "Airfuge" (n = 129), the results were essentially the same as those for all gestational ages ( Table  2 ).
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The differences between the two gestational age groups All other assay differences were not significant. were not significant (Chi square).
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